Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis

Background: Systematic comparisons of the doses of the Food and Drug Administration (FDA)-approved dual orexin receptor antagonists (DORAs) for people with insomnia are limited. Methods: PubMed, Embase, Cochrane Library, and Clinicaltrials. gov were systematically searched to identify relevant studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Tao, Wu, Xin, Li, Jiaxuan, Chen, Shujun, Wang, Zilan, Tan, Xin, Wang, Zhong, Zhang, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228643/
https://www.ncbi.nlm.nih.gov/pubmed/37261282
http://dx.doi.org/10.3389/fphar.2023.1175372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228643/
https://www.ncbi.nlm.nih.gov/pubmed/37261282
http://dx.doi.org/10.3389/fphar.2023.1175372

Ejemplares similares